Thus, our findings suggest that increased PKCδ in the CSF of patients with AD may be from microglia exposed to Aβ aggregates and that PKCδ may serve as a special biomarker for microglial‐mediated neuroinflammation in AD. The gene discussed is PRKCD; the disease is Alzheimer disease.